Literature DB >> 18849546

Osteopontin prevents curcumin-induced apoptosis and promotes survival through Akt activation via alpha v beta 3 integrins in human gastric cancer cells.

Gang Song1, Yanlin Ming, Yubin Mao, Shideng Bao, Gaoliang Ouyang.   

Abstract

Osteopontin (OPN) is a secreted, integrin-binding matrix phosphorylated glycoprotein that is overexpressed in many advanced cancers. However, the functional mechanisms by which OPN contributes to gastric cancer development are poorly understood. Here, we report that curcumin inhibited the growth of SGC7901 cell and induced apoptosis in a concentration- and time-dependent manner, while the acquired expression of OPN in SGC7901 cells dramatically promoted cell survival under serum depletion and prevented curcumin-induced apoptosis. Furthermore, PI3-K inhibitor LY294002 attenuated OPN-mediated Akt activation. Moreover, inhibiting the binding of OPN to alpha(v)beta(3) integrins reduced activation of Akt. Taken together, these results demonstrate that the pro-survival and anti-apoptosis activities of OPN in gastric cancer cells are mediated in part through PI3-K/Akt pathway via alpha(v)beta(3) integrins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849546     DOI: 10.3181/0805-RM-164

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  16 in total

1.  Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma.

Authors:  Ryan N Serio
Journal:  Cancer Microenviron       Date:  2011-11-23

Review 2.  Osteopontin: an effector and an effect of tumor metastasis.

Authors:  L A Shevde; S Das; D W Clark; R S Samant
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

3.  Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis.

Authors:  U Boltzen; A Eisenreich; S Antoniak; A Weithaeuser; H Fechner; W Poller; H P Schultheiss; N Mackman; U Rauch
Journal:  J Mol Cell Cardiol       Date:  2012-01-31       Impact factor: 5.000

4.  Ameliorating Effect of Osteopontin on H2O2-Induced Apoptosis of Human Oligodendrocyte Progenitor Cells.

Authors:  Neda Mazaheri; Maryam Peymani; Hamid Galehdari; Kamran Ghaedi; Ali Ghoochani; Abbas Kiani-Esfahani; Mohammad Hossein Nasr-Esfahani
Journal:  Cell Mol Neurobiol       Date:  2017-11-06       Impact factor: 5.046

5.  Immunohistochemical expression of osteopontin in gastric cancer.

Authors:  Motohiro Imano; Takao Satou; Tatsuki Itoh; Kenichi Sakai; Eizaburo Ishimaru; Atsushi Yasuda; Ying-Feng Peng; Masayuki Shinkai; Fumiharu Akai; Takushi Yasuda; Haruhiko Imamoto; Kiyokata Okuno; Hiroyuki Ito; Hitoshi Shiozaki; Harumasa Ohyanagi
Journal:  J Gastrointest Surg       Date:  2009-07-07       Impact factor: 3.452

6.  Function of chloride intracellular channel 1 in gastric cancer cells.

Authors:  Peng-Fei Ma; Jun-Qiang Chen; Zhen Wang; Jin-Lu Liu; Bo-Pei Li
Journal:  World J Gastroenterol       Date:  2012-06-28       Impact factor: 5.742

Review 7.  The multifaceted role of periostin in tumorigenesis.

Authors:  Kai Ruan; Shideng Bao; Gaoliang Ouyang
Journal:  Cell Mol Life Sci       Date:  2009-03-24       Impact factor: 9.261

8.  Requirement of Osteopontin in the migration and protection against Taxol-induced apoptosis via the ATX-LPA axis in SGC7901 cells.

Authors:  Rihua Zhang; Jing Wang; Shijie Ma; Zuhu Huang; Guoxin Zhang
Journal:  BMC Cell Biol       Date:  2011-03-16       Impact factor: 4.241

9.  Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines.

Authors:  Tatiana M Tilli; Akeila Bellahcène; Vincent Castronovo; Etel R P Gimba
Journal:  BMC Cancer       Date:  2014-06-13       Impact factor: 4.430

10.  Bid-overexpression regulates proliferation and phosphorylation of Akt and MAPKs in response to etoposide-induced DNA damage in hepatocellular carcinoma cells.

Authors:  Yuanyue Li; Congjie Dai; Juan Li; Weiwei Wang; Gang Song
Journal:  Onco Targets Ther       Date:  2012-10-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.